- Home
- NCRA vs AWH Comparison
NCRA vs AWH Comparison
Compare NCRA & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- AWH
- Stock Information
- Founded
- NCRA 2002
- AWH 1993
- Country
- NCRA Taiwan
- AWH United States
- Employees
- NCRA N/A
- AWH N/A
- Industry
- NCRA Farming/Seeds/Milling
- AWH Medical/Dental Instruments
- Sector
- NCRA Consumer Staples
- AWH Health Care
- Exchange
- NCRA Nasdaq
- AWH Nasdaq
- Market Cap
- NCRA 15.4M
- AWH 13.5M
- IPO Year
- NCRA N/A
- AWH N/A
- Fundamental
- Price
- NCRA $1.17
- AWH $0.82
- Analyst Decision
- NCRA
- AWH Buy
- Analyst Count
- NCRA 0
- AWH 2
- Target Price
- NCRA N/A
- AWH $4.40
- AVG Volume (30 Days)
- NCRA 5.9K
- AWH 70.4K
- Earning Date
- NCRA 08-14-2024
- AWH 11-11-2024
- Dividend Yield
- NCRA N/A
- AWH N/A
- EPS Growth
- NCRA N/A
- AWH N/A
- EPS
- NCRA N/A
- AWH N/A
- Revenue
- NCRA $26,403,874.00
- AWH $8,923,000.00
- Revenue This Year
- NCRA N/A
- AWH $15.59
- Revenue Next Year
- NCRA N/A
- AWH $108.47
- P/E Ratio
- NCRA N/A
- AWH N/A
- Revenue Growth
- NCRA 33.73
- AWH N/A
- 52 Week Low
- NCRA $0.73
- AWH $0.74
- 52 Week High
- NCRA $1.60
- AWH $6.01
- Technical
- Relative Strength Index (RSI)
- NCRA 63.58
- AWH 39.72
- Support Level
- NCRA $1.16
- AWH $0.74
- Resistance Level
- NCRA $1.10
- AWH $0.87
- Average True Range (ATR)
- NCRA 0.10
- AWH 0.06
- MACD
- NCRA 0.02
- AWH 0.02
- Stochastic Oscillator
- NCRA 84.21
- AWH 48.24
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.